TCF4 and Pitt-Hopkins syndrome: Molecular confirmation of PTHS involves the identification of heterozygous single-nucleotide or insertion-deletion variants with a loss-of-function effect or structural variants disrupting TCF4, encoding transcription factor 4, located in e18q21.2.3